NIH grant to biomedical scientist will advance research on inflammatory bowel...
University of California Riverside Declan McCole a biomedical scientist at the University of California Riverside has received a $1.83 million grant from the National Institutes of Health to identify...
View ArticleSoligenix Announces Recent Accomplishments And Second Quarter 2017 Financial...
PRINCETON N.J. Aug. 11 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare...
View ArticleScientists make critical insights into Tcell development
Mutations in the gene encoding the enzyme protein tyrosine phosphatase N2 PTPN2 have been associated with the development of autoimmune disease including Type 1 diabetes Crohn's Disease and rheumatoid...
View ArticleCritical insights into Tcell development
Mutations in the gene encoding the enzyme protein tyrosine phosphatase N2 PTPN2 have been associated with the development of autoimmune disease including Type 1 diabetes Crohn's Disease and rheumatoid...
View ArticleChemoCentryx Inc CCXI Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryChemoCentryx Inc ChemoCentryx is a biopharmaceutical company that discovers develops and commercializes orallyadministered therapeutics for the treatment of cancer autoimmune diseases and...
View ArticleDiplomat Pharmacy Inc DPLO Financial and Strategic SWOT Analysis Review...
SummaryDiplomat Pharmacy Inc Diplomat Pharmacy is a pharmaceutical company that provides medication management and clinical services. The company offers personalized medication therapies. Its services...
View ArticleNeovacs SA ALNEV Financial and Strategic SWOT Analysis Review Report Updated...
SummaryNeovacs SA Neovacs is a biotechnology company that develops various therapeutic vaccines for autoimmune disorders inflammatory diseases and cancers. The company offers TNF kinoid and IFNa kinoid...
View ArticleAevi Genomic Medicine Inc GNMX Pharmaceuticals Healthcare Deals and Alliances...
SummaryAevi Genomic Medicine Inc Aevi formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and lifealtering diseases.The...
View ArticleGalapagos NV GLPG Financial and Strategic SWOT Analysis Review Report Updated...
SummaryGalapagos NV Galapagos is a biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates targeted at the...
View ArticleImmune Pharmaceuticals Appoints Tony Fiorino MD PhD as Chief Medical Officer...
Immune Pharmaceuticals NASDAQIMNP the Immune or the Company announced today that it has appointed Tony Fiorino MD PhD to the joint position of Chief Medical Officer and Chief Operating Officer. Dr....
View ArticleProphylaxis in Crohn's Disease After Intestinal Resection
Can prophylactic drug therapy decrease the rate of clinical and endoscopic recurrence following intestinal resection for Crohn's disease Which regimen may be beneficial Frontline Gastroenterology
View ArticleNew Site Spotlights PBM Fees that Raise Medicare Costs on Seniors Seeking...
WASHINGTON Aug. 14 2017 PRNewswireUSNewswire Today the National Association of Specialty Pharmacy NASP launched StopDIRfees.com a new website that spotlights the increasingly negative consequences of...
View ArticleBeyond Pesticides Journal Articles Link Pesticides to Soil Microbiota and Gut...
WASHINGTON Aug. 14 2017 PRNewswireUSNewswire With increasing scientific understanding about the importance of beneficial bacteria in soil and the human body microbiota in the soil and microbiome in the...
View ArticleReceptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface...
LONDON Aug. 14 2017 PRNewswire Receptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC...
View ArticleReceptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface...
Receptor Tyrosine Protein Kinase ERBB 4 Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1 Pipeline Review H2...
View ArticleCalypso Biotech SA Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCalypso Biotech SA Calypso is a biopharmaceutical company that develops antibody therapies. The company's pipeline products include CALY0001 and CALY0002. Its CALY0001 therapeutic antibody is...
View ArticleImmune Pharmaceuticals Inc IMNP Medical Equipment Deals and Alliances Profile...
SummaryImmune Pharmaceuticals Inc Immune Pharma formerly EpiCept Corporation is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and...
View ArticleLab tests show molecule appears to spur cell death in tumors inflammation
Duke University Medical Center A druglike molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases including some...
View ArticleGlobal Budesonide Market Research Report 20112023 Report Updated 25072017...
SummaryBudesonide BUD sold under the brand name Pulmicort among others is a steroid medication. It is available as an inhaler pill and nasal spray.The inhaled form is used in the long term management...
View ArticleCrohn's Colitis Foundation Inc Pharmaceuticals Healthcare Deals and Alliances...
SummaryCrohn's Colitis Foundation Inc CCF is a nonprofit organization which focuses on providing treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical...
View Article